tiprankstipranks
Trending News
More News >
Alexandria Real Estate Equities (ARE)
NYSE:ARE

Alexandria Equities (ARE) AI Stock Analysis

Compare
1,150 Followers

Top Page

ARE

Alexandria Equities

(NYSE:ARE)

Select Model
Select Model
Select Model
Neutral 55 (OpenAI - 5.2)
Rating:55Neutral
Price Target:
$55.00
▲(0.66% Upside)
The score is held back primarily by weakening profitability (negative net income/ROE) and pressured cash-flow trends, partially offset by a stable balance sheet, strong liquidity and leasing metrics from the earnings call, and a high dividend yield. Technically, near-term improvement is present, but the longer-term trend remains weak.
Positive Factors
Leasing Volume
Strong leasing volume indicates robust demand for Alexandria's properties, supporting steady revenue streams and reinforcing tenant relationships.
Megacampus ARR Growth
Focus on Megacampuses enhances asset quality and revenue potential, aligning with industry trends towards large, integrated life science campuses.
Strong Financial Position
A strong liquidity position provides financial flexibility to navigate economic challenges and invest in growth opportunities.
Negative Factors
Occupancy Decline
Declining occupancy rates can lead to reduced rental income and impact the company's ability to maintain profitability in the long term.
Impairment Charges
Significant impairment charges indicate potential overvaluation of assets and can strain financial performance and investor confidence.
FFO Per Share Reduction
Reduced FFO guidance reflects challenges in maintaining profitability and could signal future financial difficulties if trends persist.

Alexandria Equities (ARE) vs. SPDR S&P 500 ETF (SPY)

Alexandria Equities Business Overview & Revenue Model

Company DescriptionAlexandria Real Estate Equities, Inc. (NYSE:ARE), an S&P 500® urban office real estate investment trust (REIT), is the first, longest-tenured, and pioneering owner, operator, and developer uniquely focused on collaborative life science, technology, and agtech campuses in AAA innovation cluster locations, with a total market capitalization of $31.9 billion as of December 31, 2020, and an asset base in North America of 49.7 million square feet (SF). The asset base in North America includes 31.9 million RSF of operating properties and 3.3 million RSF of Class A properties undergoing construction, 7.1 million RSF of near-term and intermediate-term development and redevelopment projects, and 7.4 million SF of future development projects. Founded in 1994, Alexandria pioneered this niche and has since established a significant market presence in key locations, including Greater Boston, San Francisco, New York City, San Diego, Seattle, Maryland, and Research Triangle. Alexandria has a longstanding and proven track record of developing Class A properties clustered in urban life science, technology, and agtech campuses that provide our innovative tenants with highly dynamic and collaborative environments that enhance their ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science, technology, and agtech companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.
How the Company Makes MoneyAlexandria Equities generates revenue primarily through leasing its properties to life science and technology tenants. The company operates on a long-term lease model, which provides a steady stream of rental income. Additionally, it enhances its revenue by engaging in property development and redevelopment projects, which can yield higher rental rates upon completion. The company also benefits from the increasing demand for specialized lab and office spaces, driven by growth in the biotech and pharmaceutical sectors. Significant partnerships with leading academic institutions and research organizations further bolster its revenue potential, as these collaborations often lead to increased occupancy rates and long-term leases.

Alexandria Equities Key Performance Indicators (KPIs)

Any
Any
Revenue By Segment
Revenue By Segment
Breaks down revenue by different business segments, highlighting which areas are driving growth and profitability, and where there might be challenges.
Chart InsightsAlexandria Equities shows a steady increase in Same Properties Rental Income, reflecting strong leasing activity and strategic tenant retention. Despite a decline in Same Property NOI, the company executed its largest lease ever, indicating robust demand for its properties. Non-Same Properties Rental Income fluctuates, highlighting challenges in new tenant acquisition amid a tough biotech market. Tenant Recoveries remain stable, supporting cash flow. The earnings call underscores resilience with significant asset sales and a strong credit tenant base, although occupancy challenges and asset impairments pose risks to future growth.
Data provided by:The Fly

Alexandria Equities Earnings Call Summary

Earnings Call Date:Jul 21, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Jan 26, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant achievements such as the largest lease in company history and international recognition, indicating resilience and successful execution in key areas. However, challenges were evident in occupancy declines, public biotech market struggles, and asset impairments, creating a balanced outlook.
Q2-2025 Updates
Positive Updates
Largest Lease in Company History
Alexandria secured a 466,000 square foot lease, the largest in the company's history, demonstrating resilience and long-term commitment with a high credit tenant.
Significant Progress in Asset Sales
The company completed $1.1 billion in sales in the fourth quarter of 2024 and has about $1.1 billion more to add to their executable sales pipeline for the next two quarters.
International Building of the Year Award
Alexandria won its first international Building of the Year Award for 8 Davis Drive, a 150,000 square foot R&D building, showcasing operational excellence.
Strong Venture Funding in Life Sciences
Life Science venture funding remained steady with nearly $22 billion deployed in the first half of the year, highlighting resilience in the industry.
High Quality Tenant Base
75% of annual rental revenue comes from the highly distinguished Megacampus platform, with 53% of annual rental revenue from investment-grade or publicly traded large cap tenants.
Negative Updates
Occupancy Decline
Occupancy at the end of the quarter was 90.8%, down 90 basis points from the prior quarter, reflecting challenges in maintaining leasing momentum.
Challenges in Public Biotech Markets
The public biotech equity market remains tough with no biotech IPOs in the second quarter, and the risk-off environment is affecting leasing decisions.
Same Property NOI Decline
Same property NOI was down 5.4% for the quarter due to recent declines in occupancy and the burn-off of initial free rent from last year.
Increased Free Rent Concessions
Free rent was elevated during the quarter, which, though it helped secure long-term leases, indicates challenges in tenant acquisition.
Asset Impairments
Recognized impairments of real estate of $129.6 million during the quarter, impacting financial performance.
Company Guidance
During the second quarter of 2025, Alexandria Real Estate Equities reported solid performance amidst macroeconomic challenges, highlighting several key metrics and strategic initiatives. The company executed the largest lease in its history, a 466,000 square foot build-to-suit, which underscores the trust and value of Alexandria's brand. The quarter's occupancy stood at 90.8%, with a year-end target between 90.9% and 92.5%. Same-property NOI decreased by 5.4%, while cash-based NOI increased by 2%. The company completed approximately 770,000 square feet of leasing, with tenant improvements and leasing commissions on renewals down 40% from previous quarters. Alexandria plans to add $1.1 billion to its sales pipeline over the next two quarters, having already completed $1.1 billion in sales in Q4 2024. Additionally, Alexandria reported $60 million in gains from venture investments for the first half of 2025. The company maintains a robust balance sheet with corporate credit ratings in the top 10% of all publicly traded U.S. REITs and liquidity of $4.6 billion, aiming to achieve a year-end leverage target of 5.2x net debt to adjusted EBITDA.

Alexandria Equities Financial Statement Overview

Summary
Alexandria Equities faces challenges with declining revenue growth and profitability, as evidenced by negative net income in the TTM period. While the balance sheet remains stable with a reasonable debt-to-equity ratio, the negative return on equity is concerning. Cash flow generation is under pressure, but the company maintains some ability to generate free cash flow. Overall, the financial health is mixed, with significant areas needing improvement.
Income Statement
The income statement shows a concerning trend with declining revenue growth and negative net profit margin in the TTM period. Gross profit margin remains strong, but the net income has turned negative, indicating profitability challenges. The EBIT and EBITDA margins have also decreased, reflecting operational inefficiencies.
Balance Sheet
The balance sheet is relatively stable with a moderate debt-to-equity ratio, indicating manageable leverage. However, the return on equity has turned negative in the TTM period, which is a concern. The equity ratio remains healthy, suggesting a solid asset base.
Cash Flow
Cash flow analysis reveals a decline in free cash flow growth, and the operating cash flow to net income ratio is not calculable due to negative net income. The free cash flow to net income ratio is positive, indicating some cash generation capability despite profitability issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.00B3.05B2.84B2.58B2.11B1.89B
Gross Profit2.07B2.14B1.98B1.79B1.48B1.36B
EBITDA1.25B1.90B1.45B1.77B1.62B1.17B
Net Income-413.12M322.95M103.64M521.66M571.25M770.96M
Balance Sheet
Total Assets37.38B37.53B36.77B35.52B30.22B22.83B
Cash, Cash Equivalents and Short-Term Investments579.47M552.15M618.19M825.19M361.35M568.53M
Total Debt13.96B12.75B11.70B10.57B9.23B7.91B
Total Liabilities16.26B15.13B14.15B12.84B11.19B9.38B
Stockholders Equity16.64B17.89B18.47B18.97B16.19B11.73B
Cash Flow
Free Cash Flow1.38B1.50B1.63B1.29B-6.32B882.51M
Operating Cash Flow1.38B1.50B1.63B1.29B1.01B882.51M
Investing Cash Flow-949.63M-1.51B-2.50B-5.08B-7.11B-3.28B
Financing Cash Flow-419.52M-93.31M674.16M4.23B5.92B2.75B

Alexandria Equities Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price54.64
Price Trends
50DMA
50.73
Positive
100DMA
64.94
Negative
200DMA
69.34
Negative
Market Momentum
MACD
0.74
Negative
RSI
66.13
Neutral
STOCH
95.35
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ARE, the sentiment is Neutral. The current price of 54.64 is above the 20-day moving average (MA) of 49.99, above the 50-day MA of 50.73, and below the 200-day MA of 69.34, indicating a neutral trend. The MACD of 0.74 indicates Negative momentum. The RSI at 66.13 is Neutral, neither overbought nor oversold. The STOCH value of 95.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ARE.

Alexandria Equities Risk Analysis

Alexandria Equities disclosed 11 risk factors in its most recent earnings report. Alexandria Equities reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Alexandria Equities Peers Comparison

Overall Rating
UnderperformOutperform
Sector (65)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
71
Outperform
$4.64B14.245.94%5.75%0.77%62.58%
71
Outperform
$6.72B22.5610.01%4.30%0.06%8.88%
65
Neutral
$2.17B12.193.79%4.94%3.15%1.96%
63
Neutral
$4.44B76.121.26%5.08%16.38%3.60%
59
Neutral
$11.65B-51.92-3.74%5.26%2.54%-155.17%
58
Neutral
$7.15B8.0315.97%2.24%2.41%
55
Neutral
$9.39B-22.12-2.42%10.90%-0.76%-250.60%
* Real Estate Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ARE
Alexandria Equities
54.64
-39.19
-41.77%
BXP
BXP
66.32
-2.97
-4.29%
CUZ
Cousins Properties
26.40
-2.43
-8.44%
KRC
Kilroy Realty
38.60
2.41
6.65%
VNO
Vornado Realty
33.74
-6.32
-15.78%
CDP
COPT Defense Properties
29.76
1.01
3.51%

Alexandria Equities Corporate Events

Business Operations and StrategyExecutive/Board Changes
Alexandria Equities boosts performance-based pay, promotes co-president
Positive
Jan 12, 2026

On January 9, 2026, Alexandria Real Estate Equities amended Executive Chairman Joel S. Marcus’s long-term incentive compensation for the 2025 fiscal year so that 100% of his $3.6 million target equity award is now subject to performance-based vesting rather than a mix of time- and performance-based vesting, raising the maximum potential value to $5.4 million but making all shares contingent on meeting corporate performance criteria. The company also elevated John Hart Cole to Co-President & Co-Regional Market Director – Seattle, effective January 1, 2026, building on his prior capital markets and strategic operations roles, with only a salary increase tied to the promotion, underscoring Alexandria’s emphasis on performance-linked executive pay and strengthening leadership in a key regional market.

The most recent analyst rating on (ARE) stock is a Hold with a $55.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Executive/Board ChangesStock Buyback
Alexandria Equities Announces New Stock Repurchase Program
Neutral
Dec 8, 2025

On December 3, 2025, Daniel J. Ryan, Co-President and Regional Market Director for San Diego at Alexandria Real Estate Equities, Inc., resigned from his positions due to personal and health reasons, effective December 31, 2025. Ryan had been with the company since 2010, and his departure was acknowledged with gratitude by the Board of Directors for his strategic contributions. Additionally, on December 5, 2025, Alexandria’s Board approved a new common stock repurchase program, replacing the existing authorization set to expire at the end of 2025. The new program allows for the repurchase of up to $500 million of common stock until December 31, 2026, with the company opting to fund these repurchases on a leverage-neutral basis through operating activities and real estate transactions.

The most recent analyst rating on (ARE) stock is a Hold with a $48.00 price target. To see the full list of analyst forecasts on Alexandria Equities stock, see the ARE Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026